#personalizedmedicine — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #personalizedmedicine, aggregated by home.social.
-
DATE: May 14, 2026 at 08:00PM
SOURCE: PSYPOST.ORG** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
-------------------------------------------------TITLE: Estrogen levels may dictate how the brain reacts to psychedelics, new animal study indicates
URL: https://www.psypost.org/age-and-hormones-alter-how-rats-respond-to-psilocybin-2026-03-26/
Psilocybin induces different behavioral responses in rats depending on their age and female reproductive cycles. Treating young rats with the drug, however, does not alter their behavior later in life. These outcomes indicate that psychedelic therapies may need to be customized for different patient demographics to ensure they work safely and effectively. The findings were published in the journal Neuropharmacology.
Rates of mood disorders and anxiety disorders continue to rise globally. Standard medications, like selective serotonin reuptake inhibitors, act as the most common first line of defense for these health issues. These daily medications can take weeks or even months to provide noticeable relief. They also fail to alleviate symptoms for a large portion of the people taking them, pushing medical researchers to investigate psychedelic drugs as alternative treatments.
Clinical trials suggest psilocybin might act faster, require fewer doses, and offer longer lasting relief than standard antidepressants. When a person or animal consumes psilocybin, the body rapidly breaks it down into a chemical called psilocin, which enters the brain and attaches to specific docking stations on brain cells called serotonin receptors. Activating these receptors alters consciousness, mood, and perception while promoting neuroplasticity, which is the brain’s physical ability to form new cell connections and rewire old pathways.
Historically, most studies exploring these potential therapies rely almost entirely on adult male test subjects. This blind spot exists even though major depressive episodes are notably more common in women than in men. These psychiatric conditions also frequently emerge during human adolescence, and the teenage years represent a unique period of massive brain development.
During this developmental window, brains undergo a restructuring process where massive numbers of connections between neurons are formed and then intentionally pruned away. Serotonin systems play a massive role in guiding this physical restructuring. Introducing a potent drug that alters serotonin signaling could theoretically disrupt a typical growth trajectory. A.L. Zylko, Matthew S. McMurray, and their colleagues at Miami University designed a study to evaluate these overlooked areas in psychedelic medicine.
The research team observed how rats of different ages reacted to a single dose of psilocybin. The specific psilocybin used in the study was synthesized in a laboratory using bioengineered bacteria. They gave adolescent rats either a harmless water solution or the manufactured drug. They also administered the exact same substances to fully grown adult rats to provide a baseline for comparison.
After administering the substances through a feeding tube, the researchers placed each animal in a clear observation cage and recorded their behavior on video for half an hour. They watched for a rapid, side-to-side shaking movement of the head and body. This behavior, resembling a wet dog shaking off water, is a standard marker used to measure hallucination-like states in rodents. Activating the specific serotonin receptors targeted by psilocybin reliably triggers this distinct shaking motion.
The adult rats displayed a robust increase in this behavior within five minutes of receiving the substance. The adolescent rats, on the other hand, barely reacted at all. They did not show the typical rapid head movements associated with the drug. This outcome was consistent across testing days for both early adolescent and late adolescent test groups.
The researchers then let all the young rats grow to adulthood. They wanted to see if brief exposure to the drug during a sensitive developmental period would change their adult brains in noticeable ways. Once the rats reached maturity, the team ran the subjects through a series of behavioral testing paradigms.
One test placed the animals on an elevated zero maze to measure their anxiety. This apparatus is a raised, circular track featuring open sections without walls alongside enclosed, sheltered sections. Rats instinctively fear exposed heights, meaning animals spending more time exploring the open sections show lower anxiety levels. The team found that rats previously given the psychedelic explored the track exactly like the rats given only water.
Another assessment tested how well the rats could adapt to changing rules. This task measures behavioral flexibility, a cognitive trait often impaired in individuals suffering from severe depression. The researchers restricted the animals’ food intake, then taught the hungry rats to press specific levers inside a testing chamber to receive a sugar pellet. One lever provided a sweet reward most of the time, while the other rarely dispensed an item.
Once the rats learned to favor the reliable lever, the experimenters switched the rules, making the rare lever the highly rewarding one. The animals had to figure out that the environment had changed and alter their strategy. The rats exposed to psilocybin during their youth learned the new rules just as quickly as their unexposed peers.
Finally, the researchers gave these grown rats a fresh dose of the psychedelic. They recorded their behavior to see if early adolescent exposure permanently altered their brain’s sensitivity to the chemical. Again, the early exposure made no difference in their physical response. The matured rats reacted just like adults experiencing the drug for the exact first time.
While analyzing the adult test groups, the research team noticed a clear division between the sexes. Adult female rats exhibited the shaking motion much more frequently than the adult male rats. To understand this difference, the researchers launched a secondary study focusing entirely on the female reproductive cycle.
In female rodents, this process is called the estrous cycle, and it heavily influences the structure and chemistry of the mammalian brain. The cycle involves rising and falling levels of hormones like estrogen. The researchers tracked the cycles of adult female rats for two weeks to establish their individual biological rhythms. Then, they administered psilocybin during two distinct phases of the cycle.
They tested the rats during a phase characterized by relatively low estrogen levels, called diestrus. They also tested them during a phase with peak estrogen levels, known as proestrus. The results showed a clear fluctuation in drug sensitivity that tracked directly with the hormonal shifts. Females in the low-estrogen phase displayed a higher number of shaking responses compared to when they were in the high-estrogen phase.
The researchers note that hormonal changes may alter how serotonin receptors function inside the brain. Estrogen levels might change the exact location of these receptors, pulling them off the cell surface and hiding them inside the cells where the psychedelic chemicals cannot easily reach them. Estrogen might also alter the cellular chain reactions that usually happen immediately after the drug binds to the receptor.
The researchers outline several limitations to their experimental findings. The lack of shaking behavior in the younger rats does not guarantee that the youngsters experienced no effects from the drug at all. Adolescent rats might process the drug physically faster or express the neurological effects through entirely different physical movements than adults. Preliminary tests hinted that the overall baseline number of serotonin receptors does not change drastically between age groups, but the measurement methods used had technical limitations.
Discovering that early exposure does not cause long lasting behavioral harm is a positive result, but the researchers note that developing brains naturally possess high levels of plasticity. These naturally high levels might hide the subtle structural rewiring usually triggered by the drug in adult brains. Future research should test different dosages and examine alternative behavioral markers in developing animals.
Extensively monitoring how developmental age and hormonal cycles change receptor function allows laboratory work to map onto real world conditions. Understanding these specific biological parameters will help medical professionals optimize future psychiatric drug doses for a wider diversity of patients.
The study, “Age- and estrous-dependent effects of psilocybin in rats,” was authored by A.L. Zylko, R.J. Rakoczy, B.F. Roberts, M. Wilson, A. Powell, A. Page, M. Heitkamp, D. Feist, J.A. Jones, and M.S. McMurray.
URL: https://www.psypost.org/age-and-hormones-alter-how-rats-respond-to-psilocybin-2026-03-26/
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #PsilocybinResearch #EstrogenAndBrain #PsychedelicMedicine #SexDifferencesInDrugs #EstrousCycleEffects #Neuropharmacology #SerotoninReceptors #AdolescentBrain #MentalHealthTreatments #PersonalizedMedicine
-
DATE: May 14, 2026 at 08:00PM
SOURCE: PSYPOST.ORG** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
-------------------------------------------------TITLE: Estrogen levels may dictate how the brain reacts to psychedelics, new animal study indicates
URL: https://www.psypost.org/age-and-hormones-alter-how-rats-respond-to-psilocybin-2026-03-26/
Psilocybin induces different behavioral responses in rats depending on their age and female reproductive cycles. Treating young rats with the drug, however, does not alter their behavior later in life. These outcomes indicate that psychedelic therapies may need to be customized for different patient demographics to ensure they work safely and effectively. The findings were published in the journal Neuropharmacology.
Rates of mood disorders and anxiety disorders continue to rise globally. Standard medications, like selective serotonin reuptake inhibitors, act as the most common first line of defense for these health issues. These daily medications can take weeks or even months to provide noticeable relief. They also fail to alleviate symptoms for a large portion of the people taking them, pushing medical researchers to investigate psychedelic drugs as alternative treatments.
Clinical trials suggest psilocybin might act faster, require fewer doses, and offer longer lasting relief than standard antidepressants. When a person or animal consumes psilocybin, the body rapidly breaks it down into a chemical called psilocin, which enters the brain and attaches to specific docking stations on brain cells called serotonin receptors. Activating these receptors alters consciousness, mood, and perception while promoting neuroplasticity, which is the brain’s physical ability to form new cell connections and rewire old pathways.
Historically, most studies exploring these potential therapies rely almost entirely on adult male test subjects. This blind spot exists even though major depressive episodes are notably more common in women than in men. These psychiatric conditions also frequently emerge during human adolescence, and the teenage years represent a unique period of massive brain development.
During this developmental window, brains undergo a restructuring process where massive numbers of connections between neurons are formed and then intentionally pruned away. Serotonin systems play a massive role in guiding this physical restructuring. Introducing a potent drug that alters serotonin signaling could theoretically disrupt a typical growth trajectory. A.L. Zylko, Matthew S. McMurray, and their colleagues at Miami University designed a study to evaluate these overlooked areas in psychedelic medicine.
The research team observed how rats of different ages reacted to a single dose of psilocybin. The specific psilocybin used in the study was synthesized in a laboratory using bioengineered bacteria. They gave adolescent rats either a harmless water solution or the manufactured drug. They also administered the exact same substances to fully grown adult rats to provide a baseline for comparison.
After administering the substances through a feeding tube, the researchers placed each animal in a clear observation cage and recorded their behavior on video for half an hour. They watched for a rapid, side-to-side shaking movement of the head and body. This behavior, resembling a wet dog shaking off water, is a standard marker used to measure hallucination-like states in rodents. Activating the specific serotonin receptors targeted by psilocybin reliably triggers this distinct shaking motion.
The adult rats displayed a robust increase in this behavior within five minutes of receiving the substance. The adolescent rats, on the other hand, barely reacted at all. They did not show the typical rapid head movements associated with the drug. This outcome was consistent across testing days for both early adolescent and late adolescent test groups.
The researchers then let all the young rats grow to adulthood. They wanted to see if brief exposure to the drug during a sensitive developmental period would change their adult brains in noticeable ways. Once the rats reached maturity, the team ran the subjects through a series of behavioral testing paradigms.
One test placed the animals on an elevated zero maze to measure their anxiety. This apparatus is a raised, circular track featuring open sections without walls alongside enclosed, sheltered sections. Rats instinctively fear exposed heights, meaning animals spending more time exploring the open sections show lower anxiety levels. The team found that rats previously given the psychedelic explored the track exactly like the rats given only water.
Another assessment tested how well the rats could adapt to changing rules. This task measures behavioral flexibility, a cognitive trait often impaired in individuals suffering from severe depression. The researchers restricted the animals’ food intake, then taught the hungry rats to press specific levers inside a testing chamber to receive a sugar pellet. One lever provided a sweet reward most of the time, while the other rarely dispensed an item.
Once the rats learned to favor the reliable lever, the experimenters switched the rules, making the rare lever the highly rewarding one. The animals had to figure out that the environment had changed and alter their strategy. The rats exposed to psilocybin during their youth learned the new rules just as quickly as their unexposed peers.
Finally, the researchers gave these grown rats a fresh dose of the psychedelic. They recorded their behavior to see if early adolescent exposure permanently altered their brain’s sensitivity to the chemical. Again, the early exposure made no difference in their physical response. The matured rats reacted just like adults experiencing the drug for the exact first time.
While analyzing the adult test groups, the research team noticed a clear division between the sexes. Adult female rats exhibited the shaking motion much more frequently than the adult male rats. To understand this difference, the researchers launched a secondary study focusing entirely on the female reproductive cycle.
In female rodents, this process is called the estrous cycle, and it heavily influences the structure and chemistry of the mammalian brain. The cycle involves rising and falling levels of hormones like estrogen. The researchers tracked the cycles of adult female rats for two weeks to establish their individual biological rhythms. Then, they administered psilocybin during two distinct phases of the cycle.
They tested the rats during a phase characterized by relatively low estrogen levels, called diestrus. They also tested them during a phase with peak estrogen levels, known as proestrus. The results showed a clear fluctuation in drug sensitivity that tracked directly with the hormonal shifts. Females in the low-estrogen phase displayed a higher number of shaking responses compared to when they were in the high-estrogen phase.
The researchers note that hormonal changes may alter how serotonin receptors function inside the brain. Estrogen levels might change the exact location of these receptors, pulling them off the cell surface and hiding them inside the cells where the psychedelic chemicals cannot easily reach them. Estrogen might also alter the cellular chain reactions that usually happen immediately after the drug binds to the receptor.
The researchers outline several limitations to their experimental findings. The lack of shaking behavior in the younger rats does not guarantee that the youngsters experienced no effects from the drug at all. Adolescent rats might process the drug physically faster or express the neurological effects through entirely different physical movements than adults. Preliminary tests hinted that the overall baseline number of serotonin receptors does not change drastically between age groups, but the measurement methods used had technical limitations.
Discovering that early exposure does not cause long lasting behavioral harm is a positive result, but the researchers note that developing brains naturally possess high levels of plasticity. These naturally high levels might hide the subtle structural rewiring usually triggered by the drug in adult brains. Future research should test different dosages and examine alternative behavioral markers in developing animals.
Extensively monitoring how developmental age and hormonal cycles change receptor function allows laboratory work to map onto real world conditions. Understanding these specific biological parameters will help medical professionals optimize future psychiatric drug doses for a wider diversity of patients.
The study, “Age- and estrous-dependent effects of psilocybin in rats,” was authored by A.L. Zylko, R.J. Rakoczy, B.F. Roberts, M. Wilson, A. Powell, A. Page, M. Heitkamp, D. Feist, J.A. Jones, and M.S. McMurray.
URL: https://www.psypost.org/age-and-hormones-alter-how-rats-respond-to-psilocybin-2026-03-26/
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #PsilocybinResearch #EstrogenAndBrain #PsychedelicMedicine #SexDifferencesInDrugs #EstrousCycleEffects #Neuropharmacology #SerotoninReceptors #AdolescentBrain #MentalHealthTreatments #PersonalizedMedicine
-
DATE: May 14, 2026 at 08:00PM
SOURCE: PSYPOST.ORG** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
-------------------------------------------------TITLE: Estrogen levels may dictate how the brain reacts to psychedelics, new animal study indicates
URL: https://www.psypost.org/age-and-hormones-alter-how-rats-respond-to-psilocybin-2026-03-26/
Psilocybin induces different behavioral responses in rats depending on their age and female reproductive cycles. Treating young rats with the drug, however, does not alter their behavior later in life. These outcomes indicate that psychedelic therapies may need to be customized for different patient demographics to ensure they work safely and effectively. The findings were published in the journal Neuropharmacology.
Rates of mood disorders and anxiety disorders continue to rise globally. Standard medications, like selective serotonin reuptake inhibitors, act as the most common first line of defense for these health issues. These daily medications can take weeks or even months to provide noticeable relief. They also fail to alleviate symptoms for a large portion of the people taking them, pushing medical researchers to investigate psychedelic drugs as alternative treatments.
Clinical trials suggest psilocybin might act faster, require fewer doses, and offer longer lasting relief than standard antidepressants. When a person or animal consumes psilocybin, the body rapidly breaks it down into a chemical called psilocin, which enters the brain and attaches to specific docking stations on brain cells called serotonin receptors. Activating these receptors alters consciousness, mood, and perception while promoting neuroplasticity, which is the brain’s physical ability to form new cell connections and rewire old pathways.
Historically, most studies exploring these potential therapies rely almost entirely on adult male test subjects. This blind spot exists even though major depressive episodes are notably more common in women than in men. These psychiatric conditions also frequently emerge during human adolescence, and the teenage years represent a unique period of massive brain development.
During this developmental window, brains undergo a restructuring process where massive numbers of connections between neurons are formed and then intentionally pruned away. Serotonin systems play a massive role in guiding this physical restructuring. Introducing a potent drug that alters serotonin signaling could theoretically disrupt a typical growth trajectory. A.L. Zylko, Matthew S. McMurray, and their colleagues at Miami University designed a study to evaluate these overlooked areas in psychedelic medicine.
The research team observed how rats of different ages reacted to a single dose of psilocybin. The specific psilocybin used in the study was synthesized in a laboratory using bioengineered bacteria. They gave adolescent rats either a harmless water solution or the manufactured drug. They also administered the exact same substances to fully grown adult rats to provide a baseline for comparison.
After administering the substances through a feeding tube, the researchers placed each animal in a clear observation cage and recorded their behavior on video for half an hour. They watched for a rapid, side-to-side shaking movement of the head and body. This behavior, resembling a wet dog shaking off water, is a standard marker used to measure hallucination-like states in rodents. Activating the specific serotonin receptors targeted by psilocybin reliably triggers this distinct shaking motion.
The adult rats displayed a robust increase in this behavior within five minutes of receiving the substance. The adolescent rats, on the other hand, barely reacted at all. They did not show the typical rapid head movements associated with the drug. This outcome was consistent across testing days for both early adolescent and late adolescent test groups.
The researchers then let all the young rats grow to adulthood. They wanted to see if brief exposure to the drug during a sensitive developmental period would change their adult brains in noticeable ways. Once the rats reached maturity, the team ran the subjects through a series of behavioral testing paradigms.
One test placed the animals on an elevated zero maze to measure their anxiety. This apparatus is a raised, circular track featuring open sections without walls alongside enclosed, sheltered sections. Rats instinctively fear exposed heights, meaning animals spending more time exploring the open sections show lower anxiety levels. The team found that rats previously given the psychedelic explored the track exactly like the rats given only water.
Another assessment tested how well the rats could adapt to changing rules. This task measures behavioral flexibility, a cognitive trait often impaired in individuals suffering from severe depression. The researchers restricted the animals’ food intake, then taught the hungry rats to press specific levers inside a testing chamber to receive a sugar pellet. One lever provided a sweet reward most of the time, while the other rarely dispensed an item.
Once the rats learned to favor the reliable lever, the experimenters switched the rules, making the rare lever the highly rewarding one. The animals had to figure out that the environment had changed and alter their strategy. The rats exposed to psilocybin during their youth learned the new rules just as quickly as their unexposed peers.
Finally, the researchers gave these grown rats a fresh dose of the psychedelic. They recorded their behavior to see if early adolescent exposure permanently altered their brain’s sensitivity to the chemical. Again, the early exposure made no difference in their physical response. The matured rats reacted just like adults experiencing the drug for the exact first time.
While analyzing the adult test groups, the research team noticed a clear division between the sexes. Adult female rats exhibited the shaking motion much more frequently than the adult male rats. To understand this difference, the researchers launched a secondary study focusing entirely on the female reproductive cycle.
In female rodents, this process is called the estrous cycle, and it heavily influences the structure and chemistry of the mammalian brain. The cycle involves rising and falling levels of hormones like estrogen. The researchers tracked the cycles of adult female rats for two weeks to establish their individual biological rhythms. Then, they administered psilocybin during two distinct phases of the cycle.
They tested the rats during a phase characterized by relatively low estrogen levels, called diestrus. They also tested them during a phase with peak estrogen levels, known as proestrus. The results showed a clear fluctuation in drug sensitivity that tracked directly with the hormonal shifts. Females in the low-estrogen phase displayed a higher number of shaking responses compared to when they were in the high-estrogen phase.
The researchers note that hormonal changes may alter how serotonin receptors function inside the brain. Estrogen levels might change the exact location of these receptors, pulling them off the cell surface and hiding them inside the cells where the psychedelic chemicals cannot easily reach them. Estrogen might also alter the cellular chain reactions that usually happen immediately after the drug binds to the receptor.
The researchers outline several limitations to their experimental findings. The lack of shaking behavior in the younger rats does not guarantee that the youngsters experienced no effects from the drug at all. Adolescent rats might process the drug physically faster or express the neurological effects through entirely different physical movements than adults. Preliminary tests hinted that the overall baseline number of serotonin receptors does not change drastically between age groups, but the measurement methods used had technical limitations.
Discovering that early exposure does not cause long lasting behavioral harm is a positive result, but the researchers note that developing brains naturally possess high levels of plasticity. These naturally high levels might hide the subtle structural rewiring usually triggered by the drug in adult brains. Future research should test different dosages and examine alternative behavioral markers in developing animals.
Extensively monitoring how developmental age and hormonal cycles change receptor function allows laboratory work to map onto real world conditions. Understanding these specific biological parameters will help medical professionals optimize future psychiatric drug doses for a wider diversity of patients.
The study, “Age- and estrous-dependent effects of psilocybin in rats,” was authored by A.L. Zylko, R.J. Rakoczy, B.F. Roberts, M. Wilson, A. Powell, A. Page, M. Heitkamp, D. Feist, J.A. Jones, and M.S. McMurray.
URL: https://www.psypost.org/age-and-hormones-alter-how-rats-respond-to-psilocybin-2026-03-26/
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #PsilocybinResearch #EstrogenAndBrain #PsychedelicMedicine #SexDifferencesInDrugs #EstrousCycleEffects #Neuropharmacology #SerotoninReceptors #AdolescentBrain #MentalHealthTreatments #PersonalizedMedicine
-
Top Stories from Western Switzerland (April 2026)
From Switzerland’s world-leading AI talent density to a EUR 40 million medtech raise and new milestones in fermentation…
#Switzerland #CH #Europe #Europa #EU #artificialintelligence #Biotech #crypto #education #Financing #fintech #Food&Beverages #Foodtech #headquarters #healthcare #medicaldevices #medtech #Nachrichten #Nouvelles #Personalizedmedicine #pharma #Robotics #schweiz #Suisse #switzerland
https://www.europesays.com/2953550/ -
https://www.europesays.com/ch/57526/ Top Stories from Western Switzerland (April 2026) #ArtificialIntelligence #biotech #crypto #education #Financing #FinTech #Food&Beverages #FoodTech #headquarters #Healthcare #MedicalDevices #medtech #PersonalizedMedicine #Pharma #Robotics #Switzerland
-
https://www.europesays.com/ch/48124/ Roche Receives CE Mark for Multiple Sclerosis Blood Test #biomarkers #BloodTest #CEMark #ClinicalDiagnostics #DiseaseMonitoring #immunoassay #LaboratoryTesting #MultipleSclerosis #neuroinflammation #neurology #PersonalizedMedicine #RegulatoryApproval #RelapsingRemittingMS #Roche
-
Meta’s New AI Asked for My Raw Health Data—and Gave Me Terrible Advice
-
Final Year Projects with Publication Support from BioResire!
Drug Discovery, Nanotech, NGS in Personalized Medicine—cert + e-book.
Join students: https://whatsapp.com/channel/0029Vb5u2Tp77qVTb1D7bu3r#FinalYearProject #BioResire #BiotechProjects #PublicationSupport #DrugDiscovery #Nanotech #NGS #PersonalizedMedicine #LifeSciences #Biotechnology #MScProjects #BScProjects #ResearchProjects #Bioinformatics #BioResireStudents #STEMProjects #IndiaResearch #ProjectPublication #WhatsAppCommunity #BioProjects
-
🧬 Is it possible to make whole-genome sequencing practical for everyday clinical care?
🔗 GenRiskPro: A Comprehensive Whole-Genome Sequencing Analysis Platform for Clinical and Wellness Applications. https://spj.science.org/doi/epdf/10.34133/csbj.0011
📚 CSBJ (Smart Hospital Section) - A Science Partner Journal: https://spj.science.org/page/csbj/for-authors#smarthospital
#Genomics #PrecisionMedicine #WholeGenomeSequencing #DigitalHealth #PersonalizedMedicine
-
Pipeline release! nf-core/hlatyping v2.2.0 - 2.2.0 - Holocron!
Precision HLA typing from next-generation sequencing data
Please see the changelog: https://github.com/nf-core/hlatyping/releases/tag/2.2.0#dna #hla #hlatyping #immunology #optitype #personalizedmedicine #rna #nfcore #openscience #nextflow #bioinformatics
-
The future will be personalized, precise & continuously monitored. 💊📡
know more:https://zurl.co/T4nZD
#Smidmart #TrackAndTrace #PersonalizedMedicine #RFID #SmartHealthcare #FutureOfCare #HealthTech #IIoT -
Genomics Test: What is a genomics test?
https://vaartha.com/health/what-is-a-genomics-test/609778/
#GenomicsTest #Genomics #WhatIsGenomics #DNATest #GeneticTesting #GenomeTesting #HealthTest #GenomicScience #MedicalGenetics #DNASequencing #PersonalizedMedicine #GeneticHealth #GeneTest #GenomicsExplained #HealthCheck #Biotech #GenomeAnalysis #GeneticInfo #ScienceExplained #HealthAwareness -
Genomics Test: What is a genomics test?
https://vaartha.com/health/what-is-a-genomics-test/609778/
#GenomicsTest #Genomics #WhatIsGenomics #DNATest #GeneticTesting #GenomeTesting #HealthTest #GenomicScience #MedicalGenetics #DNASequencing #PersonalizedMedicine #GeneticHealth #GeneTest #GenomicsExplained #HealthCheck #Biotech #GenomeAnalysis #GeneticInfo #ScienceExplained #HealthAwareness -
Genomics Test: What is a genomics test?
https://vaartha.com/health/what-is-a-genomics-test/609778/
#GenomicsTest #Genomics #WhatIsGenomics #DNATest #GeneticTesting #GenomeTesting #HealthTest #GenomicScience #MedicalGenetics #DNASequencing #PersonalizedMedicine #GeneticHealth #GeneTest #GenomicsExplained #HealthCheck #Biotech #GenomeAnalysis #GeneticInfo #ScienceExplained #HealthAwareness -
Genomics Test: What is a genomics test?
https://vaartha.com/health/what-is-a-genomics-test/609778/
#GenomicsTest #Genomics #WhatIsGenomics #DNATest #GeneticTesting #GenomeTesting #HealthTest #GenomicScience #MedicalGenetics #DNASequencing #PersonalizedMedicine #GeneticHealth #GeneTest #GenomicsExplained #HealthCheck #Biotech #GenomeAnalysis #GeneticInfo #ScienceExplained #HealthAwareness -
3D-printed carotid artery-on-chips for personalized thrombosis investigation
https://advanced.onlinelibrary.wiley.com/doi/10.1002/adma.202508890
#HackerNews #3Dprinting #personalizedmedicine #thrombosis #biomaterials #healthtech
-
Antidepressants: physical side-effects vary depending on the drug type – new research
#Health #Antidepressants #MentalHealth #Healthcare #PersonalizedMedicine #SideEffects #Depression #Anxiety #Wellbeing #PatientCare #Medicine #BloodPressure #Cholesterol
https://the-14.com/antidepressants-physical-side-effects-vary-depending-on-the-drug-type-new-research/ -
https://www.europesays.com/uk/490686/ Sei and WaiveDx partner to build a blockchain healthspan economy #AI #blockchain #DeSci #Diagnostics #EleanorDavies #Health #Healthcare #PersonalizedMedicine #SeiDevelopmentFoundation #UK #UnitedKingdom #WaiveDx
-
Sei and WaiveDx partner to build a blockchain healthspan economy
Collaboration aims to connect AI diagnostics, personalized health and blockchain to create an incentive-based longevity ecosystem. A new…
#NewsBeep #News #Healthcare #AI #Blockchain #DeSci #Diagnostics #EleanorDavies #Health #healthcare #PersonalizedMedicine #SeiDevelopmentFoundation #UK #UnitedKingdom #WaiveDx
https://www.newsbeep.com/uk/191899/ -
Sei and WaiveDx partner to build a blockchain healthspan economy
Collaboration aims to connect AI diagnostics, personalized health and blockchain to create an incentive-based longevity ecosystem. A new…
#NewsBeep #News #Healthcare #AI #AU #Australia #blockchain #DeSci #Diagnostics #EleanorDavies #Health #PersonalizedMedicine #SeiDevelopmentFoundation #WaiveDx
https://www.newsbeep.com/au/203463/ -
DATE: October 02, 2025 at 05:30PM
SOURCE: BioWorld MedTechDirect article link at end of text block below.
.@MHRAgovuk jumps into #PersonalizedMedicine with the ‘preference zone’
Here are any URLs found in the article text:
Articles can be found by scrolling down the page at https://www.bioworld.com/topics/85-bioworld-medtech .
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
.
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
.
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
http://subscribe-article-digests.clinicians-exchange.org
.
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
.
It's primitive... but it works... mostly...
.
-------------------------------------------------#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech
-
Join us at the 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 𝐨𝐧 𝐏𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 & 𝐀𝐈 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 (𝐇𝐞𝐚𝐥𝐭𝐡𝐀𝐈2026)
🌐 Register here: https://healthai.pagesconferences.org
📧 Contact: [email protected]
☎️ +91 6300291319#HealthAI2026 #PrecisionMedicine #AIHealthcare #FutureOfHealthcare #DigitalHealth #MedTech #HealthTech #LifeSciences #AIInHealthcare #Biotech #HealthcareInnovation #PersonalizedMedicine #HealthcareFuture #ArtificialIntelligence #DataScience #MachineLearning #DeepLearning #MedicalAI #SmartHealthcare
-
𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 𝐨𝐧 𝐏𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 & 𝐀𝐈 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 (𝐇𝐞𝐚𝐥𝐭𝐡𝐀𝐈2026) happening on 𝐉𝐮𝐥𝐲 27–28, 2026, in 𝐏𝐫𝐚𝐠𝐮𝐞, 𝐂𝐳𝐞𝐜𝐡 𝐑𝐞𝐩𝐮𝐛𝐥𝐢𝐜.
📧 𝐄𝐦𝐚𝐢𝐥: [email protected]
#HealthAI2026 #PrecisionMedicine #AIHealthcare #FutureOfHealthcare #DigitalHealth #MedTech #HealthTech #LifeSciences #AIInHealthcare #Biotech #HealthcareInnovation #PersonalizedMedicine #HealthcareFuture #ArtificialIntelligence #DataScience #MachineLearning #DeepLearning #MedicalAI #SmartHealthcare #HealthcareTechnology
-
https://www.europesays.com/uk/399183/ DNA test boosts recovery in treatment-resistant depression #AntidepressantResponse #DepressionTreatment #DNAGuidedTherapy #GeneSightTest #GeneticTestingDepression #Genetics #MajorDepressiveDisorder #PersonalizedMedicine #PharmacogenomicTesting #RemissionRatesAntidepressants #Science #TreatmentResistantDepression #UK #UnitedKingdom
-
Italian-American Researchers Present Mediterranean Diet, Health, and Longevity at Annual Medical Conference https://www.diningandcooking.com/2267988/italian-american-researchers-present-mediterranean-diet-health-and-longevity-at-annual-medical-conference/ #AlternativeMedicine #biotech #cancer #CardiovascularHealth #CellBiology #ComplementaryMedicine #Diabetes #DigestiveDisorders #FoodScience #HealthFood #Healthcare #healthspan #HeartDisease #HiddenPennsylvania #HiddenPhillyMetro #Italia #Italian #ItalianDiet #italiano #italy #Newswise #nutrition #obesity #PersonalizedMedicine #Pharmaceuticals #PublicHealth #women
-
Italian-American Researchers Present Mediterranean Diet, Health, and Longevity at Annual Medical Conference https://www.diningandcooking.com/2267988/italian-american-researchers-present-mediterranean-diet-health-and-longevity-at-annual-medical-conference/ #AlternativeMedicine #biotech #cancer #CardiovascularHealth #CellBiology #ComplementaryMedicine #Diabetes #DigestiveDisorders #FoodScience #HealthFood #Healthcare #healthspan #HeartDisease #HiddenPennsylvania #HiddenPhillyMetro #Italia #Italian #ItalianDiet #italiano #italy #Newswise #nutrition #obesity #PersonalizedMedicine #Pharmaceuticals #PublicHealth #women
-
Italian-American Researchers Present Mediterranean Diet, Health, and Longevity at Annual Medical Conference https://www.diningandcooking.com/2267988/italian-american-researchers-present-mediterranean-diet-health-and-longevity-at-annual-medical-conference/ #AlternativeMedicine #biotech #cancer #CardiovascularHealth #CellBiology #ComplementaryMedicine #Diabetes #DigestiveDisorders #FoodScience #HealthFood #Healthcare #healthspan #HeartDisease #HiddenPennsylvania #HiddenPhillyMetro #Italia #Italian #ItalianDiet #italiano #italy #Newswise #nutrition #obesity #PersonalizedMedicine #Pharmaceuticals #PublicHealth #women
-
Mitochondria, Mind, and Metabolism: The Interoceptive Frontier
#Mitochondria #Mitoception #Allostasis #Interoception #MitochondrialMedicine #EnergyMetabolism #StressResponse #PersonalizedMedicine #BrainBodyConnection #Cytokines #ATP #Angiogenesis
-
Mitochondria and Interoception: The Powerhouses Behind Your Feelings
#Interoception #BrainBodyConnection #Mitochondria #HealthScience #StressResponse #EnergyRegulation #Neuroscience #PersonalizedMedicine #BodyAwareness #HolisticHealth
-
💊 Think your prescription changes are random? Your genes might be calling the shots.
🔗 Genome-wide associations spanning 194 in-hospital drug dosage change phenotypes highlight diverse genetic backgrounds in concurrent drug therapy. Computational and Structural Biotechnology Journal, DOI: https://doi.org/10.1016/j.csbj.2025.06.042
📚 CSBJ Smart Hospital: https://www.csbj.org/smarthospital
#Genomics #Polypharmacy #PersonalizedMedicine #Pharmacogenomics #DrugSafety #GWAS #PrecisionMedicine #Pharmacology #Genetics #MedTech
-
#AI and #PersonalizedMedicine (eg multiomics) share the naive notion that one can push data through highly dimensional statistical models without any actual theory for the domain under consideration while ignoring the fact that the data available are inadequate to train/estimate said models.
-
#AI and #PersonalizedMedicine (eg multiomics) share the naive notion that one can push data through highly dimensional statistical models without any actual theory for the domain under consideration while ignoring the fact that the data available are inadequate to train/estimate said models.
-
Research Identifies Genetic Predictor of Weight Loss with GLP-1RAs
Newswise — A new study published by Cleveland Clinic researchers investigating the genetic underpinnings of wei…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Genetics #AllJournalNews #Biotech #ClevelandClinic #EthicsandResearchMethods #GLP-1;ObesityDrugs;weightlossmedications;PersonalizedMedicine;GLP-1RA;semaglutide #Newswise #Obesity #personalizedmedicine #Science #weightloss
https://www.newsbeep.com/us/20975/ -
How Tiny Genetic Changes Shape Our Thoughts, Feelings, and Behaviors
#Neuroscience #Genetics #MentalHealth #BrainScience #Neuroimaging #BehavioralScience #Endophenotypes #GeneEnvironment #PersonalizedMedicine #BrainResearch
-
How Genetics and Environment Shape Our Mental Wellbeing
#MentalHealth #Genetics #Epigenetics #Psychiatry #Genomics #Neuroscience #MentalHealthResearch #PersonalizedMedicine #BrainHealth #EnvironmentalFactors
-
From DNA to Behavior: The Fascinating World of Psychiatric Genetics
#PsychiatricGenetics #MentalHealthResearch #Genomics #Epigenetics #SNPs #BrainScience #Neurogenetics #PersonalizedMedicine #MentalHealthAwareness #Neuroscience
-
From DNA to Behavior: The Fascinating World of Psychiatric Genetics
#PsychiatricGenetics #MentalHealthResearch #Genomics #Epigenetics #SNPs #BrainScience #Neurogenetics #PersonalizedMedicine #MentalHealthAwareness #Neuroscience
-
From DNA to Behavior: The Fascinating World of Psychiatric Genetics
#PsychiatricGenetics #MentalHealthResearch #Genomics #Epigenetics #SNPs #BrainScience #Neurogenetics #PersonalizedMedicine #MentalHealthAwareness #Neuroscience
-
From DNA to Behavior: The Fascinating World of Psychiatric Genetics
#PsychiatricGenetics #MentalHealthResearch #Genomics #Epigenetics #SNPs #BrainScience #Neurogenetics #PersonalizedMedicine #MentalHealthAwareness #Neuroscience
-
Multilayer Network Neuroscience: Decoding the Brain’s Complex Systems
#NetworkNeuroscience #BrainConnectivity #Connectome #Neuroscience #BrainMapping #GraphTheory #MultilayerNetworks #BrainResearch #Neurotechnology #PersonalizedMedicine #BrainHealth #CognitiveScience #Neuroimaging #BrainScience
-
Multilayer Network Neuroscience: Decoding the Brain’s Complex Systems
#NetworkNeuroscience #BrainConnectivity #Connectome #Neuroscience #BrainMapping #GraphTheory #MultilayerNetworks #BrainResearch #Neurotechnology #PersonalizedMedicine #BrainHealth #CognitiveScience #Neuroimaging #BrainScience
-
Multilayer Network Neuroscience: Decoding the Brain’s Complex Systems
#NetworkNeuroscience #BrainConnectivity #Connectome #Neuroscience #BrainMapping #GraphTheory #MultilayerNetworks #BrainResearch #Neurotechnology #PersonalizedMedicine #BrainHealth #CognitiveScience #Neuroimaging #BrainScience
-
Multilayer Network Neuroscience: Decoding the Brain’s Complex Systems
#NetworkNeuroscience #BrainConnectivity #Connectome #Neuroscience #BrainMapping #GraphTheory #MultilayerNetworks #BrainResearch #Neurotechnology #PersonalizedMedicine #BrainHealth #CognitiveScience #Neuroimaging #BrainScience
-
Multilayer Network Neuroscience: Decoding the Brain’s Complex Systems
#NetworkNeuroscience #BrainConnectivity #Connectome #Neuroscience #BrainMapping #GraphTheory #MultilayerNetworks #BrainResearch #Neurotechnology #PersonalizedMedicine #BrainHealth #CognitiveScience #Neuroimaging #BrainScience
-
Moving Beyond Symptoms: The Science of Mental Health Foundations
#MentalHealth #Neuroscience #Psychology #PFactor #GFactor #Schemas #MentalHealthResearch #PersonalizedMedicine #SchemaTherapy #BrainScience #MentalWellbeing #IntegratedCare
-
Moving Beyond Symptoms: The Science of Mental Health Foundations
#MentalHealth #Neuroscience #Psychology #PFactor #GFactor #Schemas #MentalHealthResearch #PersonalizedMedicine #SchemaTherapy #BrainScience #MentalWellbeing #IntegratedCare
-
Moving Beyond Symptoms: The Science of Mental Health Foundations
#MentalHealth #Neuroscience #Psychology #PFactor #GFactor #Schemas #MentalHealthResearch #PersonalizedMedicine #SchemaTherapy #BrainScience #MentalWellbeing #IntegratedCare
-
Moving Beyond Symptoms: The Science of Mental Health Foundations
#MentalHealth #Neuroscience #Psychology #PFactor #GFactor #Schemas #MentalHealthResearch #PersonalizedMedicine #SchemaTherapy #BrainScience #MentalWellbeing #IntegratedCare
-
Moving Beyond Symptoms: The Science of Mental Health Foundations
#MentalHealth #Neuroscience #Psychology #PFactor #GFactor #Schemas #MentalHealthResearch #PersonalizedMedicine #SchemaTherapy #BrainScience #MentalWellbeing #IntegratedCare